#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Systemic mastocytosis Cryoglobulinaemia Epidermolysis bullosa Acute lymphocytic leukaemia recurrent Biotinidase deficiency Phenylketonuria Myelin oligodendrocyte glycoprotein antibody-associated disease Fatty acid oxidation disorder Pancreatic carcinoma metastatic Chorioretinitis Burkitt's lymphoma Acute respiratory distress syndrome Graft versus host disease Myelofibrosis Desmoid tumour More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Trials in Disease Alport’s syndrome – Life with Disease Nodal marginal zone B-cell lymphoma Alagille syndrome – Diagnostics Angelman’s syndrome – Treatment Stevens-Johnson syndrome – Life with Disease Leiomyosarcoma – Trials in Disease Von Willebrand’s disease – Basic Information IgA nephropathy – Life with Disease Mast cell activation syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Piperacillin Monohydrate Letrozole GSKVX000000034792 Ace Inhibitors, Plain Botulinum Toxin Type A Pyruvic Acid Glucocorticoids Ltp001 ADCE-D01 METAMIZOLE SODIUM Piritramide XELAFASLATIDE Vemircopan Omalizumab Mva-209-Fsp-B1 Oleclumab GOVORESTAT Amsacrine Mva-209-Fsp-B3 4-IODOPHENYLALANINE I-131 More therapies…

    Learn about Your Condition

    Post cardiac arrest syndrome Congenital ureteric anomaly Deafness traumatic Rhabdomyosarcoma Prostate cancer metastatic Hepatic cirrhosis Hereditary angioedema Skin disorder Hypoaesthesia Gouty arthritis Hepatic adenoma Psoriasis Cryoglobulinaemia Skin cancer Hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Comparing morphine and alfentanil for treating severe acute pain in adults before hospital admission

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • ALFENTANIL HYDROCHLORIDE
    • Morphine Hydrochloride
    France

  • Study of aldesleukin in children aged 4 to 6 years with autism spectrum disorder whose mothers had immune system activation during pregnancy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Aldesleukin
    France

  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Finland

  • Testing continuous versus intermittent treatment with cetuximab, fluorouracil, folinic acid, and irinotecan in patients with newly diagnosed metastatic colorectal cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cetuximab
    • Fluorouracil
    • Folinic Acid
    Germany

  • A study of mirdametinib for infants and toddlers under 24 months of age with neurofibromatosis type 1 associated plexiform neurofibromas

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Germany Spain

  • A Study of Ivosidenib and Azacitidine for Patients Over 55 with Acute Myeloid Leukemia and IDH1 Mutation in Complete Remission

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    France
Previous Page
1 … 756 757 758 759 760 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!